Pass HI - National Institutes of Health
Mesothelioma Cancer Expert at National Institutes of Health, Bethesda, MD
Mesothelioma Cancer Expert - Pass HI - Current Listing of Published Papers
The following is a listing of research papers by Pass HI in the field of mesothelioma cancer.
| Pass HI. Pleural mesothelioma in 2002: going somewhere very slowly. J Thorac Cardiovasc Surg. 2002 Dec;124(6):1074-7. Pubmed 12447170 No address listed. |
| Gadgeel SM, Pass HI. Novel combinations using pemetrexed in malignant mesothelioma. Clin Lung Cancer. 2004 Apr;5 Suppl 2:S61-6. Pubmed 15117427 Wayne State University/Karmanos Cancer Institute, Detroit, MI 48201, USA. [karmanos.org] |
| Martino D, Pass HI. Integration of multimodality approaches in the management of malignant pleural mesothelioma. Clin Lung Cancer. 2004 Mar;5(5):290-8. Pubmed 15086967 Cardiothoracic Surgery, Wayne State University, Detroit, MI, USA. |
| Pass HI, Bocchetta M, Carbone M. Evidence of an important role for SV40 in mesothelioma. Thorac Surg Clin. 2004 Nov;14(4):489-95. Pubmed 15559055 Karmanos Cancer Institute, Wayne State University School of Medicine, Harper Hospital, 3990 John R, Suite 2102, Detroit, MI 48201, USA. [dmc.org] |
| Pass HI, Vogelzang N, Hahn S, Carbone M. Malignant pleural mesothelioma. Curr Probl Cancer. 2004 May-Jun;28(3):93-174. Pubmed 15197388 Department of Surgery, Wayne State University Medical School, Detroit, Michigan, USA. |
| Carbone M, Pass HI, Miele L, Bocchetta M. New developments about the association of SV40 with human mesothelioma. Oncogene. 2003 Aug 11;22(33):5173-80. Pubmed 12910254 Department of Pathology, Cardinal Bernardin Cancer Center, Cancer Immunology Program, Loyola University Chicago, Maywood, IL 60153, USA. [orion.it.luc.edu] |
| Marom EM, Erasmus JJ, Pass HI, Patz EF Jr. The role of imaging in malignant pleural mesothelioma. Semin Oncol. 2002 Feb;29(1):26-35. Pubmed 11836666 Department of Radiology, Duke University Medical Center, Durham, NC 27710, USA. |
| Imperiale MJ, Pass HI, Sanda MG. Prospects for an SV40 vaccine. Semin Cancer Biol. 2001 Feb;11(1):81-5. Pubmed 11243902 Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor 48109-0942, USA. [umich.edu] |
| Rizzo P, Bocchetta M, Powers A, Foddis R, Stekala E, Pass HI, Carbone M. SV40 and the pathogenesis of mesothelioma. Semin Cancer Biol. 2001 Feb;11(1):63-71. Pubmed 11243900 Cancer Immunology Program, Cardinal Bernardin Cancer Center, Department of Pathology, Loyola University Chicago, Maywood, IL 60153, USA. |
| Pass HI, Robinson BW, Testa JR, Carbone M. Emerging translational therapies for mesothelioma. Chest. 1999 Dec;116(6 Suppl):455S-460S. Pubmed 10619507 Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA. [cardiology.harper.wayne.edu] |
| Carbone M, Fisher S, Powers A, Pass HI, Rizzo P. New molecular and epidemiological issues in mesothelioma: role of SV40. J Cell Physiol. 1999 Aug;180(2):167-72. Pubmed 10395286 Cancer Immunology Program, Cardinal Bernardin Cancer Center, Department of Pathology, Loyola Medical School, Maywood, Illinois 60153, USA. |
| Rizzo P, Di Resta I, Stach R, Mutti L, Picci P, Kast WM, Pass HI, Carbone M. Evidence for and implications of SV40-like sequences in human mesotheliomas and osteosarcomas. Dev Biol Stand. 1998;94:33-40. Pubmed 9776223 Cardinal Bernardin Cancer Center and Department of Pathology, Loyola University of Chicago, Maywood, Illinois 60153, USA. |
| Matker CM, Rizzo P, Pass HI, Di Resta I, Powers A, Mutti L, Kast WM, Carbone M. The biological activities of simian virus 40 large-T antigen and its possible oncogenic effects in humans. Monaldi Arch Chest Dis. 1998 Apr;53(2):193-7. Pubmed 9689808 Cardinal Bernardin Cancer Center, Loyola University of Chicago, Maywood, IL 60153, USA. |
| Carbone M, Rizzo P, Pass HI. Simian virus 40, poliovaccines and human tumors: a review of recent developments. Oncogene. 1997 Oct 16;15(16):1877-88. Pubmed 9365233 Cardinal Bernardin Cancer Center, Department of Pathology, Loyola University Chicago, Maywood, Illinois 60153, USA. |
| Friedberg JS, Mick R, Stevenson J, Metz J, Zhu T, Buyske J, Sterman DH, Pass HI, Glatstein E, Hahn SM. A phase I study of Foscan-mediated photodynamic therapy and surgery in patients with mesothelioma. Ann Thorac Surg. 2003 Mar;75(3):952-9. Pubmed 12645723 Department of Surgery, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania 19104-4283, USA. [mail.tju.edu] |
| Pass HI, Temeck BK, Kranda K, Steinberg SM, Feuerstein IR. Preoperative tumor volume is associated with outcome in malignant pleural mesothelioma. J Thorac Cardiovasc Surg. 1998 Feb;115(2):310-7; discussion 317-8. Pubmed 9475525 Thoracic Oncology Section, Warren Magnusen Clinical Center, National Institutes of Health, Bethesda, Md, USA. |
| Pass HI, Kranda K, Temeck BK, Feuerstein I, Steinberg SM. Surgically debulked malignant pleural mesothelioma: results and prognostic factors. Ann Surg Oncol. 1997 Apr-May;4(3):215-22. Pubmed 9142382 Thoracic Oncology Section, National Cancer Institute/National Institutes of Health, Bethesda, Maryland 20892, USA. |
| Pass HI, Temeck BK, Kranda K, Thomas G, Russo A, Smith P, Friauf W, Steinberg SM. Phase III randomized trial of surgery with or without intraoperative photodynamic therapy and postoperative immunochemotherapy for malignant pleural mesothelioma. Ann Surg Oncol. 1997 Dec;4(8):628-33. Pubmed 9416409 Thoracic Oncology Section, National Institutes of Health, Bethesda, Maryland, USA. |
| Elmishad AG, Bocchetta M, Pass HI, Carbone M. Polio vaccines, SV40 and human tumours, an update on false positive and false negative results. Dev Biol (Basel). 2006;123:109-17; discussion 119-32. Pubmed 16566440 Loyola University Medical Center, Cardinal Bernardin Cancer Center, Department of Pathology, Maywood, IL 60153, USA. |
| Shigematsu H, Suzuki M, Takahashi T, Miyajima K, Toyooka S, Shivapurkar N, Tomlinson GE, Mastrangelo D, Pass HI, Brambilla E, Sathyanarayana UG, Czerniak B, Fujisawa T, Shimizu N, Gazdar AF. Aberrant methylation of HIN-1 (high in normal-1) is a frequent event in many human malignancies. Int J Cancer. 2005 Feb 10;113(4):600-4. Pubmed 15472908 Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, 6000 Harry Hines Boulevard, Dallas, TX 75390-8593, USA. |
| Tsou JA, Shen LY, Siegmund KD, Long TI, Laird PW, Seneviratne CK, Koss MN, Pass HI, Hagen JA, Laird-Offringa IA. Distinct DNA methylation profiles in malignant mesothelioma, lung adenocarcinoma, and non-tumor lung. Lung Cancer. 2005 Feb;47(2):193-204. Pubmed 15639718 Norris Cancer Center and Department of Surgery and Biochemistry, Room NOR 6420, 1441 Eastlake Ave., Keck School of Medicine, University of Southern California, Los Angeles, CA 90089-9176, USA. |
| Suzuki M, Toyooka S, Shivapurkar N, Shigematsu H, Miyajima K, Takahashi T, Stastny V, Zern AL, Fujisawa T, Pass HI, Carbone M, Gazdar AF. Aberrant methylation profile of human malignant mesotheliomas and its relationship to SV40 infection. Oncogene. 2005 Feb 10;24(7):1302-8. Pubmed 15592515 Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA. |
| Pass HI, Lott D, Lonardo F, Harbut M, Liu Z, Tang N, Carbone M, Webb C, Wali A. Asbestos exposure, pleural mesothelioma, and serum osteopontin levels. N Engl J Med. 2005 Oct 13;353(15):1564-73. Pubmed 16221779 Department of Surgery, Wayne State University, Karmanos Cancer Institute, John A. Dingell Veterans Hospital, Detroit, Mich, USA. [med.nyu.edu] |
| Wali A, Morin PJ, Hough CD, Lonardo F, Seya T, Carbone M, Pass HI. Identification of intelectin overexpression in malignant pleural mesothelioma by serial analysis of gene expression (SAGE). Lung Cancer. 2005 Apr;48(1):19-29. Epub 2004 Dec 18. Pubmed 15777968 Thoracic Oncology Program, Karmanos Cancer Institute, and John D. Dingell VA Medical Center, Wayne State University, 3990 John R, Suite 2102, Detroit, MI 48201, USA. |
| Shivapurkar N, Toyooka S, Toyooka KO, Reddy J, Miyajima K, Suzuki M, Shigematsu H, Takahashi T, Parikh G, Pass HI, Chaudhary PM, Gazdar AF. Aberrant methylation of trail decoy receptor genes is frequent in multiple tumor types. Int J Cancer. 2004 May 1;109(5):786-92. Pubmed 14999791 Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, 6000 Harry Hines Boulevard, Dallas, TX 75390, USA. |
| Pass HI, Liu Z, Wali A, Bueno R, Land S, Lott D, Siddiq F, Lonardo F, Carbone M, Draghici S. Gene expression profiles predict survival and progression of pleural mesothelioma. Clin Cancer Res. 2004 Feb 1;10(3):849-59. Pubmed 14871960 Thoracic Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI 48201, USA. [dmc.org] |
| Kobatake T, Yano M, Toyooka S, Tsukuda K, Dote H, Kikuchi T, Toyota M, Ouchida M, Aoe M, Date H, Pass HI, Doihara H, Shimizu N. Aberrant methylation of p57KIP2 gene in lung and breast cancers and malignant mesotheliomas. Oncol Rep. 2004 Nov;12(5):1087-92. Pubmed 15492797 Department of Cancer and Thoracic Surgery, Graduate School of Medicine and Dentistry, Okayama University, 2-5-1 Shikata-cho, Okayama 700-8558, Japan. |
| Dote H, Tsukuda K, Toyooka S, Yano M, Pass HI, Shimizu N. Mutation analysis of the BRAF codon 599 in malignant pleural mesothelioma by enriched PCR-RFLP. Oncol Rep. 2004 Feb;11(2):361-3. Pubmed 14719068 Department of Cancer and Thoracic Surgery, Graduate School of Medicine and Dentistry, Okayama University, 2-5-1 Shikata-cho, Okayama 700-8558, Japan. |
| Lucas DR, Pass HI, Madan SK, Adsay NV, Wali A, Tabaczka P, Lonardo F. Sarcomatoid mesothelioma and its histological mimics: a comparative immunohistochemical study. Histopathology. 2003 Mar;42(3):270-9. Pubmed 12605647 Department of Pathology Wayne State University School of Medicine, Harper University Hospital, and Karmanos Cancer Institute, Detroit, MI, USA. [dmc.org] |
| Bocchetta M, Miele L, Pass HI, Carbone M. Notch-1 induction, a novel activity of SV40 required for growth of SV40-transformed human mesothelial cells. Oncogene. 2003 Jan 9;22(1):81-9. Pubmed 12527910 Department of Pathology, Cardinal Bernardin Cancer Center, Loyola University Chicago, Maywood, IL 60153, USA. |
| Lonardo F, Pass HI, Lucas DR. Immunohistochemistry frequently detects c-Kit expression in pulmonary small cell carcinoma and may help select clinical subsets for a novel form of chemotherapy. Appl Immunohistochem Mol Morphol. 2003 Mar;11(1):51-5. Pubmed 12610357 Department of Pathology, Wayne State University School of Medicine and Karmanos Cancer Institute, Detroit, MI 48201, U.S.A. [med.wayne.edu] |
| Foddis R, De Rienzo A, Broccoli D, Bocchetta M, Stekala E, Rizzo P, Tosolini A, Grobelny JV, Jhanwar SC, Pass HI, Testa JR, Carbone M. SV40 infection induces telomerase activity in human mesothelial cells. Oncogene. 2002 Feb 21;21(9):1434-42. Pubmed 11857086 Cancer Immunology Program, Department of Pathology, Cardinal Bernardin Cancer Center, Loyola University Chicago, Maywood, Illinois, IL 60153, USA. |
| Bright RK, Kimchi ET, Shearer MH, Kennedy RC, Pass HI. SV40 Tag-specific cytotoxic T lymphocytes generated from the peripheral blood of malignant pleural mesothelioma patients. Cancer Immunol Immunother. 2002 Feb;50(12):682-90. Epub 2001 Dec 13. Pubmed 11862420 Laboratory of Prostate Cancer Biology, Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, and the Oregon Cancer Center, 4805 NE Glisan Street, Portland, OR 97213, USA. [providence.org] |
| Toyooka S, Pass HI, Shivapurkar N, Fukuyama Y, Maruyama R, Toyooka KO, Gilcrease M, Farinas A, Minna JD, Gazdar AF. Aberrant methylation and simian virus 40 tag sequences in malignant mesothelioma. Cancer Res. 2001 Aug 1;61(15):5727-30. Pubmed 11479207 Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, 6000 Harry Hines Boulevard, Dallas, TX 75390, USA. |
| Bocchetta M, Di Resta I, Powers A, Fresco R, Tosolini A, Testa JR, Pass HI, Rizzo P, Carbone M. Human mesothelial cells are unusually susceptible to simian virus 40-mediated transformation and asbestos cocarcinogenicity. Proc Natl Acad Sci U S A. 2000 Aug 29;97(18):10214-9. Pubmed 10954737 Cancer Immunology Program, Department of Pathology, Cardinal Bernardin Cancer Center, Loyola University Chicago, Maywood, IL 60153, USA. |
| Marrogi A, Pass HI, Khan M, Metheny-Barlow LJ, Harris CC, Gerwin BI. Human mesothelioma samples overexpress both cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (NOS2): in vitro antiproliferative effects of a COX-2 inhibitor. Cancer Res. 2000 Jul 15;60(14):3696-700. Pubmed 10919635 Laboratory of Human Carcinogenesis, National Cancer Institute, Bethesda, Maryland 20892, USA. |
| Ohta Y, Shridhar V, Bright RK, Kalemkerian GP, Du W, Carbone M, Watanabe Y, Pass HI. VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours. Br J Cancer. 1999 Sep;81(1):54-61. Pubmed 10487612 Aerodigestive Program, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI, USA. |
| Xu L, Flynn BJ, Ungar S, Pass HI, Linnainmaa K, Mattson K, Gerwin BI. Asbestos induction of extended lifespan in normal human mesothelial cells: interindividual susceptibility and SV40 T antigen. Carcinogenesis. 1999 May;20(5):773-83. Pubmed 10334193 Laboratory of Human Carcinogenesis, National Cancer Institute, Bethesda, MD 20892, USA. |
| Scarpa S, Giuffrida A, Fazi M, Coletti A, Palumbo C, Pass HI, Procopio A, Modesti A. Migration of mesothelioma cells correlates with histotype-specific synthesis of extracellular matrix. Int J Mol Med. 1999 Jul;4(1):67-71. Pubmed 10373640 Dipartimento Medicina Sperimentale e Patologia, I-00161 Roma, Italy. |
| Hirvonen A, Mattson K, Karjalainen A, Ollikainen T, Tammilehto L, Hovi T, Vainio H, Pass HI, Di Resta I, Carbone M, Linnainmaa K. Simian virus 40 (SV40)-like DNA sequences not detectable in finnish mesothelioma patients not exposed to SV40-contaminated polio vaccines. Mol Carcinog. 1999 Oct;26(2):93-9. Pubmed 10506753 Department of Industrial Hygiene and Toxicology, Finnish Institute of Occupational Health, Helsinki, Finland. |
| Rizzo P, Carbone M, Fisher SG, Matker C, Swinnen LJ, Powers A, Di Resta I, Alkan S, Pass HI, Fisher RI. Simian virus 40 is present in most United States human mesotheliomas, but it is rarely present in non-Hodgkin’s lymphoma. Chest. 1999 Dec;116(6 Suppl):470S-473S. Pubmed 10619511 Cardinal Bernardin Cancer Center, Loyola University Chicago, Maywood, IL 60153, USA. |
| Ohta Y, Shridhar V, Kalemkerian GP, Bright RK, Watanabe Y, Pass HI. Thrombospondin-1 expression and clinical implications in malignant pleural mesothelioma. Cancer. 1999 Jun 15;85(12):2570-6. Pubmed 10375104 Aerodigestive Program, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan, USA. |
| Giuffrida A, Vianale G, Di Muzio M, Pass HI, Coletti A, Birarelli P, Procopio A, Modesti A. Modulation of integrin expression on mesotheliomas: the role of different histotypes in invasiveness. Int J Oncol. 1999 Sep;15(3):437-42. Pubmed 10427122 Dipartimento di Medicina Sperimentale e Patologia, Policlinico Umberto I, Universita degli Studi La Sapienza, Roma, Italy. |
| Pass HI, Mew DJ, Carbone M, Donington JS, Baserga R, Steinberg SM. The effect of an antisense expression plasmid to the IGF-1 receptor on hamster mesothelioma proliferation. Dev Biol Stand. 1998;94:321-8. Pubmed 9776253 Thoracic Oncology Section, NCI/NIH, Bethesda, MD, USA. |
| Pass HI, Donington JS, Wu P, Rizzo P, Nishimura M, Kennedy R, Carbone M. Human mesotheliomas contain the simian virus-40 regulatory region and large tumor antigen DNA sequences. J Thorac Cardiovasc Surg. 1998 Nov;116(5):854-9. Pubmed 9806392 Karmanos Cancer Institute Aerodigestive Program, Detroit, Mich, USA. |
| De Luca A, Baldi A, Esposito V, Howard CM, Bagella L, Rizzo P, Caputi M, Pass HI, Giordano GG, Baldi F, Carbone M, Giordano A. The retinoblastoma gene family pRb/p105, p107, pRb2/p130 and simian virus-40 large T-antigen in human mesotheliomas. Nat Med. 1997 Aug;3(8):913-6. Pubmed 9256285 Department of Pathology, Anatomy and Cell Biology and Sbarro Institute for Cancer Research and Molecular Medicine, Jefferson Medical College, Philadelphia, Pennsylvania 19107, USA. |
| Carbone M, Rizzo P, Grimley PM, Procopio A, Mew DJ, Shridhar V, de Bartolomeis A, Esposito V, Giuliano MT, Steinberg SM, Levine AS, Giordano A, Pass HI. Simian virus-40 large-T antigen binds p53 in human mesotheliomas. Nat Med. 1997 Aug;3(8):908-12. Pubmed 9256284 Cardinal Bernardin Cancer Center, Department of Pathology, Loyola University Chicago, Maywood, Illinois 60153, USA. |
